Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of platycodin D in preparing medicaments for inhibiting angiogenesis

A technology of platycodon saponin and angiogenesis, which is applied in the field of medicine and can solve the problems that platycodon saponin D has not been reported.

Inactive Publication Date: 2014-11-26
SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] However, there is no report about the application of platycodon saponin D in the preparation of drugs for inhibiting angiogenesis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of platycodin D in preparing medicaments for inhibiting angiogenesis
  • Application of platycodin D in preparing medicaments for inhibiting angiogenesis
  • Application of platycodin D in preparing medicaments for inhibiting angiogenesis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1A

[0031] Example 1A Platycodon saponin D inhibits the proliferation of human umbilical vein endothelial cells (HUVEC)

[0032] The proliferation of HUVEC was detected by CCK-8 method. CCK-8 reagent contains WST–8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfonic acid benzene) -2H-tetrazolium monosodium salt), which is reduced by the dehydrogenase in the mitochondria of the cell under the action of the electron carrier 1-Methoxy PMS (1-methoxy-5-methylphenazine dimethyl sulfate) to have Highly water-soluble yellow formazan (Formazan) product. The amount of formazan produced is directly proportional to the number of viable cells. The light absorption value was measured at a wavelength of 450 nm by an enzyme-linked immunosorbent detector, which can indirectly reflect the number of living cells. The effect of drugs on the proliferation of HUVCE can be evaluated by this method.

[0033] Methods: HUVEC cells were seeded in 96-well plates and cultured. After the c...

Embodiment 1B

[0037] Example 1B Platycodon saponin D inhibits scratch migration of human umbilical vein endothelial cells (HUVEC)

[0038]Methods: HUVEC cells were seeded in 12-well plates and cultured. After the cell growth reached 90% confluence, platycodon saponin D was added to the wells at the following concentrations of 0.3, 1, 3, 10, and 30 μM, and after 24 h of action, fresh complete medium without drugs was added to each well, and placed at 37 °C The incubator continued to incubate for 48 h, and the EVOS inverted microscope was used to take pictures. The wells without platycodon saponin D were used as the control.

[0039] Calculate the inhibition rate according to the following formula:

[0040] Inhibition rate (%) = (end point width sample - end width control ) / initial scratch width × 100%

[0041] RESULTS AND CONCLUSIONS: Please refer to the attached figure 1 B, with figure 1 B is a photograph of platycodon saponin D inhibiting the proliferation of HUVEC. As shown in ...

Embodiment 1C

[0043] Example 1C Platycodon saponin D inhibits the horizontal movement of human umbilical vein endothelial cells (HUVEC)

[0044] Using Cell Motility Kit (Cell Motility Kit) to quantitatively calculate cell motility, this experiment can predict the therapeutic effect of potential drugs in certain fields. In this experiment, cells are seeded in a 96-well plate covered with extremely small fluorescent particles. When the cells move, they will phagocytize or push away the fluorescent particles on the surface, leaving a motion estimation area without fluorescence. The area of ​​this area is the same as that of the cells. Athletic ability was positively correlated. The area of ​​motion area can be calculated by high-content screening analyzer and relevant statistical software.

[0045] Methods: Type Ⅰ collagen was used to coat the 96-well plate, the solution containing fluorescent particles was added, incubated at 37 ℃ in the dark for 1 h, and washed 5 times with washing soluti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Apertureaaaaaaaaaa
Login to View More

Abstract

The invention relates to a new application of platycodin D, namely, an application of platycodin D in preparing medicaments for inhibiting angiogenesis. The application disclosed by the invention has the advantages that a situation that platycodin D has anti-angiogenesis activity is found for the first time, so that the platycodin D can be used as an angiogenesis inhibitor; and the platycodin D can be used as an angiogenesis inhibitor, and applied to the preparation of anti-angiogenesis drugs so as to treat new vessel depended and new vessel related diseases such as cancers, arthritis, psoriasis, ophthalmic diseases, atherosclerosis, and the like.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the application of platycodon saponin D in the preparation of drugs for inhibiting angiogenesis. Background technique [0002] Angiogenesis is a complex physiological process involving a variety of cells and molecules, including endothelial cells secreting proteases to degrade the basement membrane, proliferation and migration of endothelial cells, formation of new capillary lumen structures, and recruitment of pericytes to stabilize newly formed capillaries. Vascular network, the mature vascular network is formed through the remodeling and expansion of primitive blood vessels. [0003] The dynamic balance between angiogenesis-inhibiting molecules and angiogenesis-promoting molecules is considered to be the "switch" that regulates angiogenesis. Under normal physiological conditions, the anti-angiogenic molecules and anti-angiogenic molecules are in a relative balance, and the a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/704A61P9/00A61P35/00A61P17/06A61P9/10A61P19/02
Inventor 方超陈红专栾鑫赵梅管滢芸陆琴徐见容刘亚蓉刘海军高云鸽
Owner SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com